Obstetric medication and neonatal behavior. Current controversies.
This article reviews the work on the neonatal effects of low drug doses published in the last five years. At the same time, there will be a focus on new developments in perinatal pharmacology and on current controversies in this area. The article includes discussions about neurobehavioral outcome measures and statistics, as well as recommendations for future studies.
D000700:Analgesics / Q000009:adverse effects*; D000767:Anesthesia, Epidural / Q000009:adverse effects; D000773:Anesthesia, Obstetrical / Q000009:adverse effects*; D000777:Anesthetics / Q000009:adverse effects*; D000779:Anesthetics, Local / Q000009:adverse effects; D000818:Animals; D002045:Bupivacaine / Q000009:adverse effects; D002652:Child Behavior / Q000187:drug effects*; D005260:Female; D005312:Fetal Blood / Q000187:drug effects; D006801:Humans; D007231:Infant, Newborn; D007743:Labor, Obstetric; D008614:Meperidine / Q000009:adverse effects; D009129:Muscle Tonus / Q000187:drug effects; D009460:Neurologic Examination; D010146:Pain / Q000188:drug therapy; D011247:Pregnancy; D013997:Time Factors
D000700:Analgesics; D000777:Anesthetics; D000779:Anesthetics, Local; D008614:Meperidine; D002045:Bupivacaine